HomeCompareSPXSY vs MRK

SPXSY vs MRK: Dividend Comparison 2026

SPXSY yields 2.23% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPXSY wins by $38.4K in total portfolio value· pulled ahead in Year 6
10 years
SPXSY
SPXSY
● Live price
2.23%
Share price
$45.56
Annual div
$1.02
5Y div CAGR
46.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$95.2K
Annual income
$31,864.78
Full SPXSY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SPXSY vs MRK

📍 SPXSY pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPXSYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPXSY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPXSY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPXSY
Annual income on $10K today (after 15% tax)
$189.81/yr
After 10yr DRIP, annual income (after tax)
$27,085.06/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SPXSY beats the other by $18,756.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPXSY + MRK for your $10,000?

SPXSY: 50%MRK: 50%
100% MRK50/50100% SPXSY
Portfolio after 10yr
$76.0K
Annual income
$20,831.46/yr
Blended yield
27.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SPXSY
Analyst Ratings
1
Hold
Consensus: Hold
Price Target
$70.00
+53.6% upside vs current
Range: $70.00 — $70.00
Altman Z
5.0
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPXSY buys
0
MRK buys
0
No recent congressional trades found for SPXSY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPXSYMRK
Forward yield2.23%2.76%
Annual dividend / share$1.02$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.1%32.7%
Portfolio after 10y$95.2K$56.8K
Annual income after 10y$31,864.78$9,798.13
Total dividends collected$68.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$70.00$128.54

Year-by-year: SPXSY vs MRK ($10,000, DRIP)

YearSPXSY PortfolioSPXSY Income/yrMRK PortfolioMRK Income/yrGap
1$11,026$326.24$11,206$366.19$180.00MRK
2$12,289$491.17$12,650$502.35$361.00MRK
3$13,897$747.48$14,407$694.19$510.00MRK
4$16,024$1,154.15$16,585$967.82$561.00MRK
5$18,963$1,817.09$19,342$1,363.89$379.00MRK
6← crossover$23,226$2,936.11$22,913$1,947.19+$313.00SPXSY
7$29,762$4,910.41$27,662$2,823.89+$2.1KSPXSY
8$40,437$8,591.61$34,159$4,173.35+$6.3KSPXSY
9$59,207$15,938.81$43,337$6,308.80+$15.9KSPXSY
10$95,216$31,864.78$56,776$9,798.13+$38.4KSPXSY

SPXSY vs MRK: Complete Analysis 2026

SPXSYStock

Spirax-Sarco Engineering plc provides engineered solutions for the users of industrial and commercial steam systems, electrical heating and temperature management systems, and pumps and fluid path technologies. It offers industrial and commercial steam systems, including condensate management, controls, and thermal energy management products and solutions for heating and curing, cleaning and sterilizing, hot water generation, space heating, and humidification; electrical process heating and temperature management solutions, such as industrial heaters and systems, heat tracing, and various component technologies for industrial processes, heaters, and systems; and peristaltic and niche pumps and associated fluid path technologies, including pumps, tubing, and specialty filling systems and products for single-use applications. The company serves food, beverage, pharmaceutical and biotechnology, oil, gas, chemical, healthcare, power generation, buildings, mining and precious metal processing, water and wastewater, and pulp and paper, as well as original equipment manufacturers. The company sells its products directly, as well as through distributors. It operates in Europe, the Middle East, and Africa; the Asia Pacific; and the Americas. Spirax-Sarco Engineering plc was founded in 1888 and is headquartered in Cheltenham, the United Kingdom.

Full SPXSY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SPXSY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPXSY vs SCHDSPXSY vs JEPISPXSY vs OSPXSY vs KOSPXSY vs MAINSPXSY vs JNJSPXSY vs ABBVSPXSY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.